Validation of the M. D. Anderson Symptom Inventory multiple myeloma module
详细信息 查看全文
- 作者：Desiree Jones (1)
Elisabeth G Vichaya (1)
Xin Shelley Wang (1)
Loretta A Williams (1)
Nina D Shah (2)
Sheeba K Thomas (3)
Valen E Johnson (4) (5)
Richard E Champlin (2)
Charles S Cleeland (1)
Tito R Mendoza (1) - 关键词：Symptoms ; Assessment ; Validation ; Multiple myeloma ; MDASI
- 刊名：Journal of Hematology & Oncology
- 出版年：2013
- 出版时间：December 2013
- 年：2013
- 卷：6
- 期：1
- 全文大小：277KB
- 参考文献：1. Brenner H, Gondos A, Pulte D:
2. Catley L, Anderson K:
3. Chapko MK, Syrjala KL, Schilter L, Cummings C, Sullivan KM:
4. Leger CS, Bredeson C, Kearns B, Bence-Bruckler I, Atkins H, Huebsch L:
5. Sherman AC, Simonton S, Latif U, Spohn R, Tricot G:
6. Wisloff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J:
7. Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A:
8. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC:
9. Dubois D, Dhawan R, van de Velde H, Esseltine D, Gupta S, Viala M, de la Loge C:
10. Wagner LI, Robinson D Jr, Weiss M, Katz M, Greipp P, Fonseca R, Cella D:
11. Kirkova J, Davis MP, Walsh D, Tiernan E, O’Leary N, LeGrand SB, Lagman RL, Russell KM:
12. Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS:
13. Armstrong TS, Mendoza T, Gning I, Coco C, Cohen MZ, Eriksen L, Hsu MA, Gilbert MR, Cleeland C:
14. Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS:
15. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK:
16. Willis GRB, Barofsky I:
17. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS:
18. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL:
19. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC:
20. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP:
21. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ:
22. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ:
23. Nunnally J, Bernstein IH: / Pscyhometric Theory. 3rd edition. New York: McGraw-Hill; 1994.
24. Sloan JA, Vargas-Chanes D, Kamath CC, Sargent DJ, Novotny PJ, Atherton P:
25. Cohen J: / Statistical Power Analysis for the Behavioral Sciences. 2nd edition. NJ: Lawrence Earlbaum Associates; 1988.
26. Cohen J:
27. Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS:
28. Fairclough DL:
29. Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T:
30. Nejmi M, Wang XS, Mendoza TR, Gning I, Cleeland CS:
31. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y:
32. Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS:
33. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang SM, Park SM: - 作者单位：Desiree Jones (1)
Elisabeth G Vichaya (1)
Xin Shelley Wang (1)
Loretta A Williams (1)
Nina D Shah (2)
Sheeba K Thomas (3)
Valen E Johnson (4) (5)
Richard E Champlin (2)
Charles S Cleeland (1)
Tito R Mendoza (1)
1. Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, 77030, Houston, TX, USA
2. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 423, 77030, Houston, TX, USA
3. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429, 77030, Houston, TX, USA
4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1411, 77030, Houston, TX, USA
5. Department of Statistics, Texas A&M University, 525K Blocker, 3143 TAMU, College Station, 77843-3143, Houston, TX, USA - ISSN：1756-8722
文摘
Background The symptom burden associated with multiple myeloma (MM) is often severe. Presently, no instrument comprehensively assesses disease-related and treatment-related symptoms in patients with MM. We sought to validate a module of the M. D. Anderson Symptom Inventory (MDASI) developed specifically for patients with MM (MDASI-MM). Methods The MDASI-MM was developed with clinician input, cognitive debriefing, and literature review, and administered to 132 patients undergoing induction chemotherapy or stem cell transplantation. We demonstrated the MDASI-MM’s reliability (Cronbach α values); criterion validity (item and subscale correlations between the MDASI-MM and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the EORTC MM module (QLQ-MY20)), and construct validity (differences between groups by performance status). Ratings from transplant patients were examined to demonstrate the MDASI-MM’s sensitivity in detecting the acute worsening of symptoms post-transplantation. Results The MDASI-MM demonstrated excellent correlations with subscales of the 2 EORTC instruments, strong ability to distinguish clinically different patient groups, high sensitivity in detecting change in patients-performance status, and high reliability. Cognitive debriefing confirmed that the MDASI-MM encompasses the breadth of symptoms relevant to patients with MM. Conclusion The MDASI-MM is a valid, reliable, comprehensive-yet-concise tool that is recommended as a uniform symptom assessment instrument for patients with MM.